Proton Pump Inhibitors: Are They a Real Threat to the Patient?
Background: Proton pump inhibitors are among the most frequently prescribed drugs in the world and are generally considered safe. However, there is growing concern regarding their safety. Summary: A nonsystematic review of the current literature was performed regarding proton pump inhibitors and the...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2018-02-01
|
Series: | GE: Portuguese Journal of Gastroenterology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/487154 |
id |
doaj-322332bf19e1462aa5bb7fe8a2760a9d |
---|---|
record_format |
Article |
spelling |
doaj-322332bf19e1462aa5bb7fe8a2760a9d2020-11-25T02:47:41ZengKarger PublishersGE: Portuguese Journal of Gastroenterology2341-45452387-19542018-02-0110.1159/000487154487154Proton Pump Inhibitors: Are They a Real Threat to the Patient?Sofia XavierJoana MagalhãesJosé CotterBackground: Proton pump inhibitors are among the most frequently prescribed drugs in the world and are generally considered safe. However, there is growing concern regarding their safety. Summary: A nonsystematic review of the current literature was performed regarding proton pump inhibitors and their adverse effects. Proton pump inhibitors seem to be associated with fundic gland polyp development (without clinical relevance) and Clostridium difficile infection. Also, in cirrhotic patients, their prescription should be carefully reviewed. Regarding their association with other enteric infections, micronutrient deficiency, dementia, and chronic kidney disease, current evidence is still of low quality, and further studies are needed. Key Messages: Considering the current evidence, most patients with a clear clinical indication for proton pump inhibitor treatment should probably benefit from the maintenance of their treatment without significant adverse effects. However, higher-quality studies are needed to confirm or dismiss most of the proposed adverse effects.https://www.karger.com/Article/FullText/487154Proton pump inhibitorsSafetyAdverse effects |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sofia Xavier Joana Magalhães José Cotter |
spellingShingle |
Sofia Xavier Joana Magalhães José Cotter Proton Pump Inhibitors: Are They a Real Threat to the Patient? GE: Portuguese Journal of Gastroenterology Proton pump inhibitors Safety Adverse effects |
author_facet |
Sofia Xavier Joana Magalhães José Cotter |
author_sort |
Sofia Xavier |
title |
Proton Pump Inhibitors: Are They a Real Threat to the Patient? |
title_short |
Proton Pump Inhibitors: Are They a Real Threat to the Patient? |
title_full |
Proton Pump Inhibitors: Are They a Real Threat to the Patient? |
title_fullStr |
Proton Pump Inhibitors: Are They a Real Threat to the Patient? |
title_full_unstemmed |
Proton Pump Inhibitors: Are They a Real Threat to the Patient? |
title_sort |
proton pump inhibitors: are they a real threat to the patient? |
publisher |
Karger Publishers |
series |
GE: Portuguese Journal of Gastroenterology |
issn |
2341-4545 2387-1954 |
publishDate |
2018-02-01 |
description |
Background: Proton pump inhibitors are among the most frequently prescribed drugs in the world and are generally considered safe. However, there is growing concern regarding their safety. Summary: A nonsystematic review of the current literature was performed regarding proton pump inhibitors and their adverse effects. Proton pump inhibitors seem to be associated with fundic gland polyp development (without clinical relevance) and Clostridium difficile infection. Also, in cirrhotic patients, their prescription should be carefully reviewed. Regarding their association with other enteric infections, micronutrient deficiency, dementia, and chronic kidney disease, current evidence is still of low quality, and further studies are needed. Key Messages: Considering the current evidence, most patients with a clear clinical indication for proton pump inhibitor treatment should probably benefit from the maintenance of their treatment without significant adverse effects. However, higher-quality studies are needed to confirm or dismiss most of the proposed adverse effects. |
topic |
Proton pump inhibitors Safety Adverse effects |
url |
https://www.karger.com/Article/FullText/487154 |
work_keys_str_mv |
AT sofiaxavier protonpumpinhibitorsaretheyarealthreattothepatient AT joanamagalhaes protonpumpinhibitorsaretheyarealthreattothepatient AT josecotter protonpumpinhibitorsaretheyarealthreattothepatient |
_version_ |
1724752059505311744 |